Cargando…
DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification
PURPOSE: To compare functional and anatomical results of combined phacoemulsification and dexamethasone intravitreal implant (Ozurdex; DEX-I) with standard phacoemulsification in diabetic patients with cataract. METHODS: Retrospective, comparative, cohort study. Patients with nonproliferative diabet...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Retina
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078110/ https://www.ncbi.nlm.nih.gov/pubmed/32897932 http://dx.doi.org/10.1097/IAE.0000000000002974 |
_version_ | 1783685003445534720 |
---|---|
author | Furino, Claudio Boscia, Francesco Niro, Alfredo D'Addario, Maria Grassi, Maria O. Saglimbene, Valeria Reibaldi, Michele Alessio, Giovanni |
author_facet | Furino, Claudio Boscia, Francesco Niro, Alfredo D'Addario, Maria Grassi, Maria O. Saglimbene, Valeria Reibaldi, Michele Alessio, Giovanni |
author_sort | Furino, Claudio |
collection | PubMed |
description | PURPOSE: To compare functional and anatomical results of combined phacoemulsification and dexamethasone intravitreal implant (Ozurdex; DEX-I) with standard phacoemulsification in diabetic patients with cataract. METHODS: Retrospective, comparative, cohort study. Patients with nonproliferative diabetic retinopathy, macular edema, and cataract, treated routinely at the Eye Clinic, Azienda Ospedaliero Universitaria Policlinico, Bari, Italy with phacoemulsification associated with DEX-I (n = 23; Phaco-Dex) or standard phacoemulsification (n = 23; Phaco-alone). Best-correct visual acuity, central subfield thickness, and intraocular pressure were assessed at baseline and monthly for 3 months after surgery, and t-test was used to assess change from baseline. A multilevel regression model with an unstructured correlation-type matrix to account for repeated data measures was used for statistical analysis in and between groups. RESULTS: With Phaco-Dex, best-correct visual acuity increased significantly from the first month (P = 0.0005 vs. baseline) and remained stable at the following visits; central subfield thickness decreased significantly from Month 2 (P = 0.049 and P = 0.04 vs. baseline, respectively); at each timepoint, central subfield thickness was significantly lower in the Phaco-Dex group versus Phaco-alone. Intraocular pressure increased significantly during follow-up (P = 0.001 at Month 3 vs. baseline) but remained within the normal range. In the Phaco-alone group, best-correct visual acuity, and intraocular pressure did not show any significant changes after surgery, whereas central subfield thickness increased from Month 2 (P = 0.05 vs. baseline). CONCLUSION: In diabetic patients with macular edema and visually significant cataract, combined treatment with phacoemulsification and DEX-I seemed to be effective, safe, and superior to standard phacoemulsification considering both functional and tomographic parameters. |
format | Online Article Text |
id | pubmed-8078110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Retina |
record_format | MEDLINE/PubMed |
spelling | pubmed-80781102021-05-04 DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification Furino, Claudio Boscia, Francesco Niro, Alfredo D'Addario, Maria Grassi, Maria O. Saglimbene, Valeria Reibaldi, Michele Alessio, Giovanni Retina Original Study PURPOSE: To compare functional and anatomical results of combined phacoemulsification and dexamethasone intravitreal implant (Ozurdex; DEX-I) with standard phacoemulsification in diabetic patients with cataract. METHODS: Retrospective, comparative, cohort study. Patients with nonproliferative diabetic retinopathy, macular edema, and cataract, treated routinely at the Eye Clinic, Azienda Ospedaliero Universitaria Policlinico, Bari, Italy with phacoemulsification associated with DEX-I (n = 23; Phaco-Dex) or standard phacoemulsification (n = 23; Phaco-alone). Best-correct visual acuity, central subfield thickness, and intraocular pressure were assessed at baseline and monthly for 3 months after surgery, and t-test was used to assess change from baseline. A multilevel regression model with an unstructured correlation-type matrix to account for repeated data measures was used for statistical analysis in and between groups. RESULTS: With Phaco-Dex, best-correct visual acuity increased significantly from the first month (P = 0.0005 vs. baseline) and remained stable at the following visits; central subfield thickness decreased significantly from Month 2 (P = 0.049 and P = 0.04 vs. baseline, respectively); at each timepoint, central subfield thickness was significantly lower in the Phaco-Dex group versus Phaco-alone. Intraocular pressure increased significantly during follow-up (P = 0.001 at Month 3 vs. baseline) but remained within the normal range. In the Phaco-alone group, best-correct visual acuity, and intraocular pressure did not show any significant changes after surgery, whereas central subfield thickness increased from Month 2 (P = 0.05 vs. baseline). CONCLUSION: In diabetic patients with macular edema and visually significant cataract, combined treatment with phacoemulsification and DEX-I seemed to be effective, safe, and superior to standard phacoemulsification considering both functional and tomographic parameters. Retina 2021-05 2021-04-22 /pmc/articles/PMC8078110/ /pubmed/32897932 http://dx.doi.org/10.1097/IAE.0000000000002974 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Opthalmic Communications Society, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Study Furino, Claudio Boscia, Francesco Niro, Alfredo D'Addario, Maria Grassi, Maria O. Saglimbene, Valeria Reibaldi, Michele Alessio, Giovanni DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification |
title | DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification |
title_full | DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification |
title_fullStr | DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification |
title_full_unstemmed | DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification |
title_short | DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification |
title_sort | diabetic macular edema and cataract surgery: phacoemulsification combined with dexamethasone intravitreal implant compared with standard phacoemulsification |
topic | Original Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078110/ https://www.ncbi.nlm.nih.gov/pubmed/32897932 http://dx.doi.org/10.1097/IAE.0000000000002974 |
work_keys_str_mv | AT furinoclaudio diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification AT bosciafrancesco diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification AT niroalfredo diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification AT daddariomaria diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification AT grassimariao diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification AT saglimbenevaleria diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification AT reibaldimichele diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification AT alessiogiovanni diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification |